• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度尼西亚结核病治疗项目的流行病学模型与成本效益分析

Epidemiological model and cost-effectiveness analysis of tuberculosis treatment programmes in Indonesia.

作者信息

Joesoef M R, Remington P L, Jiptoherijanto P T

机构信息

Division of Chronic Disease Control, Centers for Disease Control, Atlanta, Georgia 30333.

出版信息

Int J Epidemiol. 1989 Mar;18(1):174-9. doi: 10.1093/ije/18.1.174.

DOI:10.1093/ije/18.1.174
PMID:2498217
Abstract

An epidemiological model of tuberculosis, based on the natural history of tuberculosis and the control programmes in Indonesia, was constructed. This model was used for estimating future tuberculosis-prevented cases and costs for three treatment strategies--the 100% standard course, the 100% short course, and the existing strategy (a combination of 65% standard course and 35% short course)--in accordance with the master plan of the Indonesian Government's tuberculosis control programme. A cost-effectiveness analysis of the three strategies confirmed that the short-course strategy was the most cost-effective. Sensitivity analysis, which applied a broad range of parameters, continued to confirm the short-course strategy as the most cost-effective. If the short-course strategy had been applied in 1980 instead of the existing strategy (using the most likely parameters), the short-course strategy would prevent 1.8 million sputum-positive cases and would save 61.0 million dollars by the year 2000.

摘要

基于结核病的自然史和印度尼西亚的控制规划,构建了一个结核病流行病学模型。该模型用于根据印度尼西亚政府结核病控制规划的总体计划,估算三种治疗策略(100%标准疗程、100%短程疗法和现有策略,即65%标准疗程与35%短程疗法的组合)未来预防的结核病病例数和成本。对这三种策略的成本效益分析证实,短程疗法策略是最具成本效益的。应用广泛参数的敏感性分析继续证实短程疗法策略是最具成本效益的。如果在1980年采用短程疗法策略而非现有策略(使用最可能的参数),到2000年,短程疗法策略将预防180万痰涂片阳性病例,并节省6100万美元。

相似文献

1
Epidemiological model and cost-effectiveness analysis of tuberculosis treatment programmes in Indonesia.印度尼西亚结核病治疗项目的流行病学模型与成本效益分析
Int J Epidemiol. 1989 Mar;18(1):174-9. doi: 10.1093/ije/18.1.174.
2
Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania.马拉维、莫桑比克和坦桑尼亚痰涂片阳性肺结核化疗的成本效益
Int J Health Plann Manage. 1994 Apr-Jun;9(2):151-81. doi: 10.1002/hpm.4740090204.
3
The comparison of tuberculosis treatments: a short course therapy and the directly observed short course treatment (DOTS), East Java Province, Indonesia.印度尼西亚东爪哇省结核病治疗方法的比较:短程疗法与直接观察短程治疗(DOTS)
Southeast Asian J Trop Med Public Health. 2000 Mar;31(1):85-8.
4
Method to elaborate a national programme of short-course chemotherapy: experience of Romania.制定国家短期化疗计划的方法:罗马尼亚的经验
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1986 Jan-Mar;35(1):23-9.
5
Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries.撒哈拉以南非洲三个国家肺结核化疗的成本效益
Lancet. 1991 Nov 23;338(8778):1305-8. doi: 10.1016/0140-6736(91)92600-7.
6
Social, economic and operational research on tuberculosis: recent studies and some priority questions.结核病的社会、经济与运营研究:近期研究及若干优先问题
Bull Int Union Tuberc Lung Dis. 1991 Dec;66(4):149-56.
7
Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. China Tuberculosis Control Collaboration.112842例中国涂片阳性肺结核患者直接观察短程化疗的结果。中国结核病控制协作组
Lancet. 1996 Feb 10;347(8998):358-62.
8
DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.柬埔寨的直接督导下短程化疗。
Int J Tuberc Lung Dis. 1998 Jan;2(1):44-51.
9
Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis.结核病直接督导治疗与自我给药治疗的成本效益
Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1013-9. doi: 10.1164/ajrccm.154.4.8887600.
10
Cost effectiveness of DOTS and non-DOTS strategies for smear-positive pulmonary tuberculosis in Beijing.北京涂阳肺结核直接督导下短程化疗策略与非直接督导下短程化疗策略的成本效益分析
Biomed Environ Sci. 2000 Dec;13(4):307-13.

引用本文的文献

1
Heightened vulnerability to MDR-TB epidemics after controlling drug-susceptible TB.控制耐多药结核病后,对耐多药结核病流行的脆弱性增加。
PLoS One. 2010 Sep 22;5(9):e12843. doi: 10.1371/journal.pone.0012843.
2
Cost effectiveness of antituberculosis interventions.抗结核干预措施的成本效益
Pharmacoeconomics. 1995 Nov;8(5):385-99. doi: 10.2165/00019053-199508050-00003.
3
Defining criteria for the pharmacoeconomic evaluation of new oral cephalosporins.确定新型口服头孢菌素药物经济学评价的标准。
Pharmacoeconomics. 1994;5(Suppl 2):11-9. doi: 10.2165/00019053-199400052-00004.
4
Indices of therapeutic outcome in pharmacoeconomic evaluation of drug therapy.药物治疗的药物经济学评价中的治疗结果指标。
Pharmacoeconomics. 1992 Mar;1(3):155-60. doi: 10.2165/00019053-199201030-00002.
5
Pharmacoeconomics of antibacterial treatment.抗菌治疗的药物经济学
Pharmacoeconomics. 1992 Jun;1(6):409-37. doi: 10.2165/00019053-199201060-00003.
6
Preventive strategy and general practice.预防策略与全科医疗
Br J Gen Pract. 1993 Apr;43(369):138-9.